The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab
Titel:
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab
Auteur:
Papadopoulou, Erofili Nicolatou-Galitis, Ourania Papassotiriou, Ioannis Linardou, Helena Karagianni, Aikaterini Tsixlakis, Konstantinos Tarampikou, Anthi Michalakakou, Kelly Vardas, Emmanouil Bafaloukos, Dimitrios